| Literature DB >> 31520363 |
Assel Mukasheva1, Nurbek Saparkhojayev2, Zhanay Akanov3, Amy Apon4, Sanjay Kalra5.
Abstract
INTRODUCTION: The prevalence of diabetes in Kazakhstan has reached epidemic proportions, and this disease is becoming a major financial burden. In this research, regression analysis methods were employed to build models for predicting the number of diabetic patients in Kazakhstan in 2019, as this should aid the costing and policy-making performed by medical institutions and governmental offices regarding diabetes prevention and treatment strategies.Entities:
Keywords: Data analysis; Diabetes mellitus; Forecasting; Python; Regression analysis; Scikit-learn; Statistics
Year: 2019 PMID: 31520363 PMCID: PMC6848515 DOI: 10.1007/s13300-019-00684-1
Source DB: PubMed Journal: Diabetes Ther Impact factor: 2.945
The total number of patients with diabetes mellitus (DM) in Kazakhstan during each of the last 15 years
| Year | Number of patients with DM in Kazakhstan |
|---|---|
| 2004 | 114,355 |
| 2005 | 117,563 |
| 2006 | 128,039 |
| 2007 | 147,717 |
| 2008 | 151,336 |
| 2009 | 162,012 |
| 2010 | 175,685 |
| 2011 | 190,682 |
| 2012 | 207,935 |
| 2013 | 226,202 |
| 2014 | 261,453 |
| 2015 | 272,629 |
| 2016 | 293,171 |
| 2017 | 310,114 |
| 2018 | 326,449 |
Fig. 1Data from the register of patients with DM in Kazakhstan
The correlation coefficient for population growth versus number of DM patients in each region of Kazakhstan
| Population growth in the region | Number of patients with DM in the region | ||||||
|---|---|---|---|---|---|---|---|
| Akmola | Aktobe | Almaty | Atyrau | West Kazakhstan | Jambyl | Karaganda | |
| Akmola | − 0.2856 | ||||||
| Aktobe | 0.96606 | ||||||
| Almaty | 0.9023 | ||||||
| Atyrau | 0.97796 | ||||||
| West Kazakhstan | 0.9445 | ||||||
| Jambyl | 0.95496 | ||||||
| Karaganda | 0.98211 | ||||||
| Kostanay | |||||||
| Kyzylorda | |||||||
| Mangistau | |||||||
| South Kazakhstan | |||||||
| Pavlodar | |||||||
| North Kazakhstan | |||||||
| East Kazakstan | |||||||
| Astana city | |||||||
| Almaty city | |||||||
The correlation coefficient for growth in GRP versus growth in the number of patients with DM in each region of Kazakhstan
| Growth in GRP of region | Growth in the number of DM patients in the region | |||||||
|---|---|---|---|---|---|---|---|---|
| Akmola | Aktobe | Almaty | Atyrau | West Kazakhstan | Jambyl | Karaganda | Kostanay | |
| Akmola | 0.83894 | |||||||
| Aktobe | 0.94669 | |||||||
| Almaty | 0.99265 | |||||||
| Atyrau | 0.94822 | |||||||
| West Kazakhstan | 0.95174 | |||||||
| Jambyl | 0.96482 | |||||||
| Karaganda | 0.98211 | |||||||
| Kostanay | 0.93 | |||||||
| Kyzylorda | ||||||||
| Mangistau | ||||||||
| South Kazakhstan | ||||||||
| Pavlodar | ||||||||
| North Kazakhstan | ||||||||
| East Kazakstan | ||||||||
| Astana city | ||||||||
| Almaty city | ||||||||
The number of DM patients in each region of Kazakhstan in the year 2019, as predicted using three regression analysis methods
| Numerical label for region | Region | Linear regression | Polynomial regression | Exponential regression |
|---|---|---|---|---|
| 1 | Akmola | 16,110 | 16,187 | 17,957 |
| 2 | Aktobe | 14,107 | 15,189 | 16,150 |
| 3 | Almaty | 31,222 | 30,867 | 36,074 |
| 4 | Atyrau | 8882 | 9419 | 10,580 |
| 5 | West Kazakhstan | 9446 | 10,225 | 10,817 |
| 6 | Jambyl | 17,172 | 19,725 | 18,472 |
| 7 | Karaganda | 31,500 | 31,569 | 33,915 |
| 8 | Kostanay | 22,444 | 25,198 | 23,805 |
| 9 | Kyzylorda | 10,453 | 11,852 | 13,304 |
| 10 | Mangistau | 9399 | 10,609 | 11,624 |
| 11 | South Kazakhstan | 39,085 | 38,867 | 42,957 |
| 12 | Pavlodar | 18,612 | 20,445 | 20,082 |
| 13 | North Kazakhstan | 17,554 | 17,137 | 19,236 |
| 14 | East Kazakhstan | 34,932 | 35,993 | 37,296 |
| 15 | Astana | 15,254 | 16,240 | 17,976 |
| 16 | Almaty | 36,837 | 40,552 | 39,702 |
| 17 | The Republic of Kazakhstan | 333,010 | 350,074 | 369,945 |
Fig. 2Plot showing the number of DM patients in Kazakhstan each year from 2004 to 2018, as well as three different regression lines fitted to the data. The regression lines were used to predict the number of DM patients in Kazakhstan in 2019